Newly approved clot-busting drug works as well as traditional drug for stroke, research shows
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...
Le Lézard4h
Perfuze Receives FDA 510(k) Clearance for Ziplinetm Access Catheters and Secures ?22M in Additional Funding
Perfuze, a leading medical device company dedicated to advancing stroke treatment, today announced that it has received FDA 510(k) clearance for its Ziplinetm Access Catheters. This regulatory ...
Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding
Perfuze, a leading medical device company dedicated to advancing stroke treatment, today announced that it has received FDA ...
Exoskeleton and digital twin speed up stroke recovery
Researchers at the Technical University of Munich (TUM) have developed a system that helps patients learn to move their ...
The Cardiology Advisor20h
TNKase Approved for Treatment of Acute Ischemic Stroke
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
'I suffered a stroke after having three sinister symptoms - that's why they're dangerous'
American sprint icon Michael Johnson, who won four Olympic gold medals, suffered a stroke in 2018 and opened up about the ...
The Cardiology Advisor23h
Developing Dementia After Stroke: What Is the Risk for Stroke Survivors?
Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.
Infectious Disease Advisor23h
Patients With COVID-19 Have Worse Recovery Outcomes Following Ischemic Stroke
A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.